Abstract | OBJECTIVE: SUBJECTS AND METHODS: RESULTS: Ninety nine patients, mean age 56 years (SD 5), mean diabetes duration 7 years (S.D. 7), mean glycated hemoglobin (7.3%) were enrolled. There was no significant difference between the groups for any of the primary hemostasis criteria (n=77). Triglycerides (TG) variation significantly differed between groups, P=0.01, from -21% in the large patch group, to +22% in the placebo group (n=82). Treatment administration routes did not significantly differ for any of the criteria. There was a significant difference in the total cholesterol variation between groups, from +8.7% in the placebo group to -10.8% in the oral 1 mg group (P=0.001). CONCLUSION: The treatments had no highly deleterious effect in these patients with NIDDM or with IGT. Long-term trials can be performed with such patients, and an hormone treatment can be prescribed to relieve symptoms. Since these patients had a well-controlled NIDDM, results might be different in less well-controlled diabetes. The data do not support the hypothesis of an impaired oestrogen effect in patients with NIDDM.
|
Authors | C Cornu, C Mercier, P Ffrench, C Bully, M Pugeat, P Cousin, J P Riou, L Bajart, J Orgiazzi, C Pommet-Nicot, P Darsy, J P Boissel, F Berthezène |
Journal | Maturitas
(Maturitas)
Vol. 37
Issue 2
Pg. 95-104
(Dec 29 2000)
ISSN: 0378-5122 [Print] Ireland |
PMID | 11137328
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Estrogens
- Chlormadinone Acetate
- Norethindrone Acetate
- Norethindrone
|
Topics |
- Biomarkers
(blood)
- Chlormadinone Acetate
(administration & dosage)
- Diabetes Mellitus, Type 2
(blood)
- Double-Blind Method
- Drug Therapy, Combination
- Estrogens
(administration & dosage, adverse effects, therapeutic use)
- Female
- Glucose Intolerance
(blood)
- Hormone Replacement Therapy
(adverse effects, methods)
- Humans
- Informed Consent
- Middle Aged
- Norethindrone
(administration & dosage, analogs & derivatives)
- Norethindrone Acetate
- Postmenopause
(blood)
|